Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS101 with Chemotherapy for Elderly AML and MDS
NCT01010373Phase 2Suspended
- Sponsor
- BioMAS Ltd
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AS-101 in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by BioMAS Ltd. Started Jan 2015; status: suspended.
02
Drugs
AS-101
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01010373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01010373.